← UNITEDHEALTH GROUP INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $184.8b | $201.2b | $226.2b | $242.2b | $257.1b | $287.6b | $324.2b | $371.6b | $400.3b | $447.6b | |
| Revenues: | |||||||||||
| Revenue from Products and Services | — | — | — | $50.6b | $54.2b | $59.0b | $65.0b | $76.7b | $86.3b | $91.4b | |
| Cost of Revenue | $24.4b | $24.1b | $27.0b | $28.1b | $30.7b | $31.0b | $33.7b | $38.8b | $46.7b | $50.7b | |
| Gross Profit (Calculated) | $160.4b | $177.0b | $199.2b | $214.0b | $226.4b | $256.6b | $290.5b | $332.9b | $353.6b | $396.9b | |
| Operating costs | $28.4b | $29.6b | $34.1b | $35.2b | $41.7b | $42.6b | $47.8b | $54.6b | $53.0b | $59.6b | |
| Total operating costs | $171.9b | $185.9b | $208.9b | $222.5b | $234.7b | $263.6b | $295.7b | $339.3b | $368.0b | $428.6b | |
| Operating Income (Loss) | $12.9b | $15.2b | $17.3b | $19.7b | $22.4b | $24.0b | $28.4b | $32.4b | $32.3b | $19.0b | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $882.0m | $896.0m | $898.0m | $1.0b | $1.1b | $1.2b | $1.3b | $1.6b | $1.7b | $1.7b | |
| Capitalized Computer Software, Amortization | $475.0m | $550.0m | $606.0m | $721.0m | $814.0m | $923.0m | $1.0b | $1.2b | $1.4b | $1.7b | |
| Depreciation and amortization | $2.1b | $2.2b | $2.4b | $2.7b | $2.9b | $3.1b | $3.4b | $4.0b | $4.1b | $4.4b | |
| Dilutive effect of common share equivalents | $16.0m | $21.0m | $20.0m | $15.0m | $12.0m | $13.0m | $13.0m | $10.0m | $8.0m | $3.0m | |
| Earnings attributable to noncontrolling interests | ($56.0m) | ($265.0m) | ($396.0m) | ($400.0m) | ($366.0m) | ($447.0m) | ($519.0m) | ($763.0m) | ($837.0m) | ($751.0m) | |
| Earnings from operations | $12.9b | $15.2b | $17.3b | $19.7b | $22.4b | $24.0b | $28.4b | $32.4b | $32.3b | $19.0b | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | — | — | — | — | — | — | — | $28.3b | $14.9b | |
| Investment and other income | $828.0m | $1.0b | $1.4b | $1.9b | $1.5b | $2.3b | $2.0b | $4.1b | $5.2b | $3.9b | |
| Loss on sale of subsidiary and subsidiaries held for sale | — | — | — | — | — | — | $0 | $0 | ($8.3b) | ($265.0m) | |
| Net earnings | $7.1b | $10.8b | $12.4b | $14.2b | $15.8b | $17.7b | $20.6b | $23.1b | $15.2b | $12.8b | |
| Net earnings attributable to UnitedHealth Group common shareholders | $7.0b | $10.6b | $12.0b | $13.8b | $15.4b | $17.3b | $20.1b | $22.4b | $14.4b | $12.1b | |
| Premiums | $144.1b | $158.5b | $178.1b | $189.7b | $201.5b | $226.2b | $257.2b | $290.8b | $308.8b | $352.2b | |
| Provision for income taxes | ($4.8b) | ($3.2b) | ($3.6b) | ($3.7b) | ($5.0b) | ($4.6b) | ($5.7b) | ($6.0b) | ($4.8b) | ($1.9b) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | $18.0b | $20.7b | $22.3b | $26.3b | $29.1b | $20.1b | $14.7b | |
| Policyholder Benefits and Claims Incurred, Net | — | — | — | — | — | — | — | — | $264.2b | $314.0b | |
| Premiums Earned, Net | $144.1b | $158.5b | $178.1b | $189.7b | $201.5b | $226.2b | $257.2b | $290.8b | $308.8b | $352.2b | |
| Total income before income taxes | — | — | — | $18.0b | $20.7b | $22.3b | $26.3b | $29.1b | $20.1b | $14.7b | |
| Net Income (Loss) Attributable to Parent | $7.0b | $10.6b | $12.0b | $13.8b | $15.4b | $17.3b | $20.1b | $22.4b | $14.4b | $12.1b | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $56.0m | $265.0m | $396.0m | $400.0m | $366.0m | $447.0m | $519.0m | $763.0m | $837.0m | $751.0m | |
| Common Stock, Dividends, Per Share, Declared | $2.38 | $2.88 | — | — | — | — | — | — | — | — | |
| Earnings Per Share, Basic | $7.37 | $10.95 | $12.45 | $14.55 | $16.23 | $18.33 | $21.47 | $24.12 | $15.64 | $13.28 | |
| Earnings Per Share, Diluted | $7.25 | $10.72 | $12.19 | $14.33 | $16.03 | $18.08 | $21.18 | $23.86 | $15.51 | $13.23 | |
| Basic weighted-average number of common shares outstanding | 952.0m | 964.0m | 963.0m | 951.0m | 949.0m | 943.0m | 937.0m | 928.0m | 921.0m | 908.0m | |
| Diluted weighted-average number of common shares outstanding | 968.0m | 985.0m | 983.0m | 966.0m | 961.0m | 956.0m | 950.0m | 938.0m | 929.0m | 911.0m | |
| Weighted Average Number of Shares Outstanding, Basic | 952.0m | 964.0m | 963.0m | 951.0m | 949.0m | 943.0m | 937.0m | 928.0m | 921.0m | 908.0m | |
| Weighted Average Number of Shares Outstanding, Diluted | 968.0m | 985.0m | 983.0m | 966.0m | 961.0m | 956.0m | 950.0m | 938.0m | 929.0m | 911.0m | |
| Expenses | |||||||||||
| Cost of products sold | $24.4b | $24.1b | $27.0b | $28.1b | $30.7b | $31.0b | $33.7b | $38.8b | $46.7b | $50.7b | |
| Costs and Expenses | $171.9b | $185.9b | $208.9b | $222.5b | $234.7b | $263.6b | $295.7b | $339.3b | $368.0b | $428.6b | |
| Current Income Tax Expense (Benefit) | $4.7b | $4.2b | $3.5b | $3.5b | $5.0b | $4.4b | $6.4b | $6.2b | $5.1b | $3.6b | |
| Interest Expense | $1.1b | $1.2b | $1.4b | $1.7b | $1.7b | $1.7b | $2.1b | $3.2b | $3.9b | $4.0b | |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | $117.0b | $130.0b | $145.4b | $156.4b | $159.4b | $186.9b | $210.8b | $241.9b | $264.2b | $314.0b | |
| Medical costs | $117.0b | $130.0b | $145.4b | $156.4b | $159.4b | $186.9b | $210.8b | $241.9b | $264.2b | $314.0b | |
| Restructuring Costs | — | — | — | — | — | — | — | — | — | $2.5b | |
| Selling, General and Administrative Expense | $28.4b | $29.6b | $34.1b | $35.2b | $41.7b | $42.6b | $47.8b | $54.6b | $53.0b | $59.6b | |
| Income Tax Expense (Benefit) | $4.8b | $3.2b | $3.6b | $3.7b | $5.0b | $4.6b | $5.7b | $6.0b | $4.8b | $1.9b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.